Skip to content
Search

Latest Stories

Integrated healthcare system could enable pharmacists to provide effective, efficient patient care: PDA

The lessons from Covid crisis applied in the future through collaboration can create a better integration between GP practices, hospitals and community pharmacies, Pharmacists Defence Association (PDA) has proposed.

Stating that a more integrated healthcare system could enable pharmacists to provide effective and more efficient care to patients, the PDA proposed a model where at least two pharmacists would be working in each community pharmacy, empowered, and enabled with two-way referral pathways, having more clinical input and full access to patient records.


“Such an environment could not only help to improve communications between health professionals and increase access to services for patients, but would support the NHS to operate more effectively.”

While the report by the PDA published last week (Aug 12) requires a rethink of the contribution of community pharmacy, it believes the objectives outlined in the proposals could be achieved with right political will and support from across the sector.

The association believes that the Covid-19 pandemic not only highlighted some of the inefficiencies in the current system but also displayed the level of flexibility that can be adopted when needed.

The report from the PDA illustrates how to achieve this potential.

“With some changes having already occurred, such as the greater use of technology for virtual consultations, it is important to build upon the pandemic experience and embrace a more integrated and collaborative approach to providing health and social care.”

The report has been developed through the combined views and feedback of PDA members. Lord Philip Hunt of Kings Heath, a House of Lords health spokesperson and former minister of state at the Department of Health and Social Care was able to attend a recent meeting of external stakeholders at the House of Lords which discussed the report’s proposals and has written the foreword to the report.

Alison Jones, PDA director of policy said: “The PDA recognises that more than ever before, the NHS needs to adapt and innovate and be integrated with social care. We know that health and social care must move forward and provide high-quality care and address public health issues before they become endemic.

"We also recognise that with the right funding and structures pharmacists based in a variety of settings, including those in local communities, are best placed to carry out many functions and that is what these latest proposals set out to address.”

The report shows how, because of their expertise and accessible positioning, pharmacists can assist with the delivery of the diagnostic programme, and how they can deliver pharmaceutical care to patients previously diagnosed with long term conditions.

The proposals not only create far greater capacity in other parts of the health system, but they dramatically improve the patient's journey.

“This level of collaboration will not happen organically; the joined-up care being advocated can only be delivered through a Community of Practice which is supported by a locally managed system. Members of the healthcare team have been working hard and the system is nearing breaking point. The breaking down of the historical silo approach to healthcare commissioning with a focus upon collaboration will enable the NHS to work smarter for the benefit of the NHS, the workforce and ultimately to the patients that we serve,” said PDA in its report.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less